A Phase II/III, Multi-center, Randomized, Double Blind, Placebo Controlled and Parallel Assignment Study to Evaluate the Safety and Efficacy of HN-VAC (Influenza A/H1N1 Adjuvant vaccine) Produced by BBIL in healthy volunteers.
Phase of Trial: Phase II/III
Latest Information Update: 24 Aug 2016
At a glance
- Drugs Influenza A virus vaccine-H1N1 (Primary)
- Indications Influenza A virus H1N1 subtype
- Focus Adverse reactions
- Sponsors Bharat Biotech
- 21 Mar 2012 Additional lead trial investigator identified as reported by Clinical Trials Registry - India.
- 27 Oct 2011 Status changed from active, no longer recruiting to completed as reported by Clinical Trials Registry - India.
- 04 Aug 2010 New trial record